AMPHETAMINES EIA ASSAY MODIFICATION— 510(k) K934891

Name: FDA 510(k) clearance K934891
Creator: U.S. Food and Drug Administration
Published: 1994-01-13

Substantially Equivalent

Diagnostic Reagents, Inc.

FDA 510(k) clearance K934891 for AMPHETAMINES EIA ASSAY MODIFICATION, Substantially Equivalent on 1994-01-13. Applicant: Diagnostic Reagents, Inc.. Device class: 2.

Clearance details

Applicant: Diagnostic Reagents, Inc.
Product code: Code DKZ
Device class: Class 2
Regulation: 21 CFR 862.3100
Advisory panel: Clinical Toxicology
Date received: 1993-09-21
Decision date: 1994-01-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mountain View, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DKZ

view all

K240670 — DRI Ecstasy Plus Assay2024-10-30
K233019 — AllTest Multi-Drug Rapid Test Cup +3 more2023-12-13
K231137 — Xenta Drug Screen Cup, Xenta Drug Screen Dipcard2023-05-19
K200363 — Quidel Triage® TOX Drug Screen, 946002020-03-11
K191099 — Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel2019-10-03

More clearances from Diagnostic Reagents, Inc.

view all

K983268 — MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY1998-11-18
K983812 — NAPA EIA ASSAY1998-11-16
K983323 — DIGOXIN IMMUNOASSAY1998-11-12
K983280 — VANCOMYCIN EIA ASSAY1998-11-06
K983159 — DRUGS OF ABUSE URINE CALIBRATORS AND CONTROLS1998-11-05

Data sourced from openFDA. This site is unofficial and independent of the FDA.